Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART budesonide/formoterol versus fixed fluticasone/salmeterol in COPD
NL-OMON44539Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing SMART Spiromax budesonide/formoterol with Fixed Diskus fluticasone/salmeterol plus salbutamol (2 arms). Primary endpoint: Reduction in number of exacerbations. Started May 2015; status: active, not recruiting.
02
Drugs
budesonideformoterolfluticasonesalmeterolsalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON44539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44539.